Cannabinoid-Induced Inhibition of Morphine Glucuronidation and the Potential for In Vivo Drug-Drug Interactions
Opioids are commonly prescribed for the treatment of chronic pain. Approximately 50% of adults who are prescribed opioids for pain co-use cannabis with their opioid treatment. Morphine is primarily metabolized by UDP-glucuronosyltransferase (UGT) 2B7 to an inactive metabolite, morphine-3-glucuronide...
Saved in:
Main Authors: | Shelby Coates (Author), Keti Bardhi (Author), Philip Lazarus (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabinoid-Induced Stereoselective Inhibition of R-S-Oxazepam Glucuronidation: Cannabinoid-Oxazepam Drug Interactions
by: Keti Bardhi, et al.
Published: (2024) -
The TLR4-active morphine metabolite morphine-3-glucuronide does not elicit macrophage classical activation in vitro
by: Samira Khabbazi, et al.
Published: (2016) -
Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteers
by: Thomas Duflot, et al.
Published: (2022) -
Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats
by: Agnieszka Karbownik, et al.
Published: (2021) -
Increased sinusoidal export of drug glucuronides is a compensative mechanism in liver cirrhosis of mice
by: Rebekka Fendt, et al.
Published: (2023)